Evidence map›Paper›PMID 37956792›Full record

ArticleContemporary clinical trials2024

Protocol of a patient randomized clinical trial to improve medication adherence in primary care.

JoAnn M Sperl-Hillen, Jacob L Haapala, Steven P Dehmer, Lilian N Chumba, Heidi L Ekstrom, Anjali R Truitt, Stephen E Asche, Ann M Werner, Dan J Rehrauer, Melissa A Pankonin and 2 more

Open access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

JoAnn M Sperl-HillenHealthPartners Institute, Bloomington, MN, United States. Electronic address: Joann.M.Sperlhillen@healthpartners.com.
Jacob L HaapalaHealthPartners Institute, Bloomington, MN, United States.
Steven P DehmerHealthPartners Institute, Bloomington, MN, United States.
Lilian N ChumbaHealthPartners Institute, Bloomington, MN, United States.
Heidi L EkstromHealthPartners Institute, Bloomington, MN, United States.
Anjali R TruittMemorial Hermann, Houston, TX, United States.
Stephen E AscheHealthPartners Institute, Bloomington, MN, United States.
Ann M WernerHealthPartners Institute, Bloomington, MN, United States.
Dan J RehrauerHealthPartners Health Plan, Bloomington, MN, United States; HealthPartners Medical Group, Bloomington, MN, United States.
Melissa A PankoninHealthPartners Health Plan, Bloomington, MN, United States.
Pamala A PawloskiHealthPartners Institute, Bloomington, MN, United States.
Patrick J O'ConnorHealthPartners Institute, Bloomington, MN, United States.
HealthPartners · USMemorial Hermann · US

Funding

A Team-Based and Technology Driven Adherence Intervention to Improve Chronic Disease OutcomesR01HL136937 · NHLBI · HEALTHPARTNERS INSTITUTE · PI SPERL-HILLEN, JOANN M · 2018 to 2022
$3.6M
NHLBI NIH HHS R01 HL136937
6 · The paper itself

Abstract

backgroundEnhanced awareness of poor medication adherence could improve patient care. This article describes the original and adapted protocols of a randomized trial to improve medication adherence for cardiometabolic conditions.

methodsThe original protocol entailed a cluster randomized trial of 28 primary care clinics allocated to either (i) medication adherence enhanced chronic disease care clinical decision support (eCDC-CDS) integrated within the electronic health record (EHR) or (ii) usual care (non-enhanced CDC-CDS). Enhancements comprised (a) electronic interfaces printed for patients and clinicians at primary care encounters that encouraged discussion about specific medication adherence issues that were identified, and (b) pharmacist phone outreach. Study subjects were individuals who at an index visit were aged 18-74 years and not at evidence-based care goals for hypertension (HTN), diabetes mellitus (DM), or lipid management, along with low medication adherence (proportion of days covered [PDC] <80%) for a corresponding medication. The primary study outcomes were improved medication adherence and clinical outcomes (BP and A1C) at 12 months. Protocol adaptation became imperative in response to major implementation challenges: (a) the availability of EHR system-wide PDC calculations that superseded our ability to limit PDC adherence information solely to intervention clinics; (b) the unforeseen closure of pharmacies committed to conducting the pharmacist outreach; and (c) disruptions and clinic closures due to the Covid-19 pandemic.

conclusionThis manuscript details the protocol of a study to assess whether enhanced awareness of medication adherence issues in primary care settings could improve patient outcomes. The need for protocol adaptation arose in response to multiple implementation challenges.

Indexed as

Diabetes MellitusHypertensionAdolescentAdultAgedHumansMedication AdherenceMiddle AgedPandemicsPrimary Health CareRandomized Controlled Trials as TopicYoung AdultChronic diseaseClinical decision supportMedication adherencePharmacist outreachPrimary care

Identifiers

PMID37956792
PMCPMC10922408
OpenAlexW4388591794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.